Establishment of the definite cell line of brain-derived neurotrophic factor gene-modified human bone marrow mesenchymal stem cells
Ping Su,Chang-jun Lu,Lian-xu Zhao,Yan-hua Li,Li-dong Guan,Yun-fang Wang,Bing-xun Lu,Xue-tao Pei
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.45.005
2006-01-01
Abstract:Aim: To establish brain-derived neurotrophic factor (BDNF) gene-modified human bone marrow mesenchymal stem (BDNF-MSCs) cell line. Methods: The experiment was conducted in the Research Center for Stem Cell, Beijing Academy of Military Medical Sciences between February 2004 and June 2005. Human bone marrow mesenchymal stem cells (MSCs) were provided by 6 healthy adult marrow donors including 3 males and 3 females aged 25-45 years treated by marrow transplantation in the 307 Hospital of Chinese PLA. MSCs were isolated and incubated by routine way, and the surface antibodies of CD34, CD44 and CD45 were detected by flow cytometry. The BDNF genes were transfected to human MSCs with recombinant retrovirus vector containing human BDNF gene. The proliferation and BDNF protein expression were detected, and exogenous BDNF genes in BDNF-MSCs were detected by PCR. Results: (1) The artificial MSCs possessed unanimous morphous and size with long spindle or long polygon from passage 0 to passage 20, positive expression of CD44 and negative expression of CD34 and CD45 were found in MSCs of passage 2. (2) The infection rate of retrovirus infecting MSCs was about 10%, there were no difference between BDNF-MSCs and MSCs in morphology and proliferation rate, but BDNF-MSCs could not proliferate after passage 10. Immunocytochemical staining suggested the positive rate BDNF exceeded 98% in BDNF-MSCs, content of BDNF in medium was increased 20 000 times in BDNF-MSCs than that in MSCs. (3) Exogenous BDNF gene belt was discovered in BDNF-MSCs after amplification by PCR. Conclusion: Stable BDNF gene-modified human bone marrow mesenchymal stem cell line is established by retrovirus vectors, which provide a kind of seed cell with multiple potential adult stem cells as carrier.